SCHEDULE 13G - CHRISTOPHER FORBES

Company

Eloxx Pharmaceuticals, Inc.

Filed

November 19, 1999

Accession Number

0001015357-99-000134

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →